OBJECTIVE: Acute renal failure (ARF) frequently complicates lung transplantation. This study determined the prevalence, predictive factors, and consequences of ARF on long-term renal function and survival. METHODS: One hundred and seventy-four lung transplantation recipients were divided into two groups based on the presence or absence of ARF defined as a 50% decrease in creatinine clearance from baseline (group I: 67 patients with ARF; group II: 107 patients without ARF). Multivariate analysis compared pre-operative, operative, and post-operative risk factors to assess predictive factors. Renal function over time was assessed by two-way repeated measures analysis of variance (ANOVA). RESULTS: ARF developed in 67 (39%) of patients. Multivariate analysis identified aprotinin (OR 2.20 (1.11; 4.36), p=0.02) and double lung transplantation (OR 2.61 (1.32; 5.15), p=0.006) as risk factors for post-operative renal failure. At 5 years following transplant, creatinine clearance was similar between the two groups (group I CrCl: 73 ml s(-1); group II CrCl: 53 ml s(-1); p=0.54). Survival at 5 years was the same in the two groups. Multivariate analysis associated age at the time of transplantation (HR 1.030 (1.004; 1.057), p=0.02) and intensive care unit (ICU) length of stay (HR 1.029 (1.008; 1.051), p=0.007) with decreased survival. CONCLUSIONS: The use of aprotinin and double lung transplantation are associated with ARF following lung transplantation. Age at the time of transplantation and a longer intensive care stay predict decreased survival. ARF after lung transplantation is not predictive of late renal dysfunction or decreased long-term survival.
OBJECTIVE:Acute renal failure (ARF) frequently complicates lung transplantation. This study determined the prevalence, predictive factors, and consequences of ARF on long-term renal function and survival. METHODS: One hundred and seventy-four lung transplantation recipients were divided into two groups based on the presence or absence of ARF defined as a 50% decrease in creatinine clearance from baseline (group I: 67 patients with ARF; group II: 107 patients without ARF). Multivariate analysis compared pre-operative, operative, and post-operative risk factors to assess predictive factors. Renal function over time was assessed by two-way repeated measures analysis of variance (ANOVA). RESULTS:ARF developed in 67 (39%) of patients. Multivariate analysis identified aprotinin (OR 2.20 (1.11; 4.36), p=0.02) and double lung transplantation (OR 2.61 (1.32; 5.15), p=0.006) as risk factors for post-operative renal failure. At 5 years following transplant, creatinine clearance was similar between the two groups (group I CrCl: 73 ml s(-1); group II CrCl: 53 ml s(-1); p=0.54). Survival at 5 years was the same in the two groups. Multivariate analysis associated age at the time of transplantation (HR 1.030 (1.004; 1.057), p=0.02) and intensive care unit (ICU) length of stay (HR 1.029 (1.008; 1.051), p=0.007) with decreased survival. CONCLUSIONS: The use of aprotinin and double lung transplantation are associated with ARF following lung transplantation. Age at the time of transplantation and a longer intensive care stay predict decreased survival. ARF after lung transplantation is not predictive of late renal dysfunction or decreased long-term survival.
Authors: Dean A Fergusson; Paul C Hébert; C David Mazer; Stephen Fremes; Charles MacAdams; John M Murkin; Kevin Teoh; Peter C Duke; Ramiro Arellano; Morris A Blajchman; Jean S Bussières; Dany Côté; Jacek Karski; Raymond Martineau; James A Robblee; Marc Rodger; George Wells; Jennifer Clinch; Roanda Pretorius Journal: N Engl J Med Date: 2008-05-14 Impact factor: 91.245
Authors: A de Mendonça; J L Vincent; P M Suter; R Moreno; N M Dearden; M Antonelli; J Takala; C Sprung; F Cantraine Journal: Intensive Care Med Date: 2000-07 Impact factor: 17.440
Authors: Areef Ishani; Sehsuvar Erturk; Marshall I Hertz; Arthur J Matas; Kay Savik; Mark E Rosenberg Journal: Kidney Int Date: 2002-06 Impact factor: 10.612
Authors: R K Sibley; G J Berry; H D Tazelaar; M R Kraemer; J Theodore; S E Marshall; M E Billingham; V A Starnes Journal: J Heart Lung Transplant Date: 1993 Mar-Apr Impact factor: 10.247
Authors: Akinlolu O Ojo; Philip J Held; Friedrich K Port; Robert A Wolfe; Alan B Leichtman; Eric W Young; Julie Arndorfer; Laura Christensen; Robert M Merion Journal: N Engl J Med Date: 2003-09-04 Impact factor: 91.245
Authors: Asishana A Osho; Anthony W Castleberry; Laurie D Snyder; Asvin M Ganapathi; Sameer A Hirji; Mark Stafford-Smith; Shu S Lin; R Duane Davis; Matthew G Hartwig Journal: Ann Thorac Surg Date: 2014-05-01 Impact factor: 4.330
Authors: M Alrawashdeh; R Zomak; M A Dew; S Sereika; M K Song; J M Pilewski; A DeVito Dabbs Journal: Am J Transplant Date: 2016-10-27 Impact factor: 8.086
Authors: Su Hwan Lee; Moo Suk Park; Joo Han Song; Young Sam Kim; Jin Gu Lee; Hyo Chae Paik; Song Yee Kim Journal: J Thorac Dis Date: 2017-10 Impact factor: 2.895